Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intelligent Scopes
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Intelligent Scopes' lead programs include CystoSmart for bladder cancer (under FDA review) and Helga iCAP for colonic lesion detection. Initial validation suggests improved diagnostic accuracy for clinicians using these AI-assisted tools; commercial launch anticipated after regulatory clearance in H2 2024.
- Therapeutic areas
- Oncology
- Modalities
- DeviceSoftwareArtificial intelligence
- Industry
- Digital Health Medical Devices
02
Partnerships
Mayo ClinicKhoo Teck Puat Hospital (KTPH), SingaporeSingapore’s National Healthcare Group (NHG) Centre for Medical Technologies and Innovations
Beyond the preview
Go deeper on Intelligent Scopes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intelligent Scopes.